Australasian ophthalmic technology distribution company Eyetek is poised to unveil the new MS-39 anterior segment optical coherence tomography (AS-OCT) system to ophthalmologists in New Zealand and Australia.
Though the official roll-out continues to be delayed by the coronavirus pandemic, Eyetek managing director Jeremy Rebion said the MS-39 leaves the current Scheimpflug imaging system standard behind. “The MS-39 AS-OCT is the most advanced, accurate and repeatable device for the analysis of the anterior segment of the eye. It’s a game changer for refractive surgeons for surgery planning and follow ups, further improving the patient’s surgery outcome and comfort.”
A spectral domain OCT system, the MS-39 combines Placido disc corneal topography with high resolution OCT-based anterior segment tomography to provide information on ocular surface diseases, epithelial thickness, pachymetry, elevation, curvature and dioptric power of both corneal surfaces, said Rebion. “The clarity of the cross-sectional images, with a 16mm diameter, along with the many details of the cornea structure and layers revealed by the MS-39 are simply impeccable and will be appreciated by anterior segment specialists.”
An intraocular lens calculation module is also available, based on ray tracing techniques, while additional tools enable the MS-39 to perform accurate pupil diameter measurements and advanced tear film analysis, he said.
In a technology assessment in Mivision, Australian cataract and refractive surgeon Dr Rick Wolfe concluded, “If I were allowed only one instrument in refractive surgery, the MS-39 would exceed requirements.” While London-based, dedicated laser eye surgeon Professor Dan Reinstein said, the MS-39 “is so, so far ahead of the rest of the industry, it’s actually embarrassing.”
